Fundraising Fox
/Companies
Sign in

Vertos Medical

Aliso Viejo, US · Delaware corporation · 3 known investors

Find your way into Vertos Medical

Sign up to see every warm intro you have to Vertos Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vertos Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Vertos Medical (part of Stryker's Interventional Spine business) develops minimally invasive interventional treatments for chronic pain and reduced mobility, including vertebral augmentation, bone tumor ablation, and basivertebral nerve ablation. Its products are aimed at physicians and clinicians treating patients with vertebral compression fractures, metastatic bone tumors, and related spinal conditions.

HealthtechMedical Devices

Founders & leadership

EWEric Wichems
Eric WichemsPresident & Chief Executive OfficerEric Wichems is an executive at Vertos Medical with more than a decade of experience in product development, product launches, sales management, and marketing for medical device companies, including venture-funded startups.
RCRebecca Colbert
Rebecca ColbertChief Financial Officer and Chief Operating Officer2014–2024Rebecca Colbert is an executive at Vertos Medical who has held financial leadership roles, with experience in operations management, financing transactions, M&A, and commercialization strategy across multiple companies that have pursued acquisition or IPO processes.
BF
Bruce FeuchterNamed on SEC filing

Board

MG
Myles GreenbergBoard director
DP
Daniel PelakBoard director
IHIttai Harel
Ittai HarelDirector Board Of Directors2013–2024Managing Partner | HealthTech at Pitango
JR
John RyanBoard director

Investors · 3

MVM Life Science PartnersreportedLondon · $20M – $100M

How we know: board seat on SEC Form D · funding news · Not right? Tell us

PitangoreportedTel Aviv · $2M – $40Mvia Ittai Harel · board

How we know: a partner's Signal profile · board seat on SEC Form D · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$122.2M disclosed across 5 of 6 rounds · 2014–2023

▶$44.6MraisedJun 2023 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel PelakDirector
  • Mike BoggsDirector
  • Eric WichemsExecutive Officer, Director
  • Ittai HarelDirector
  • Hugo HarrodDirector
  • Zachary ScottDirector
  • Rebecca ColbertExecutive Officer
Offering amount
$45.6M
Amount sold
$44.6M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.8MraisedNov 2021 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric WichemsExecutive Officer, Director
  • Hugo HarrodDirector
  • Bruce FeuchterExecutive Officer
  • Robert KuhlingDirector
  • Daniel PelakDirector
  • Ittai HarelDirector
  • Rebecca ColbertExecutive Officer
Offering amount
$17M
Amount sold
$16.8M
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.1MraisedSep 2019 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel PelakDirector
  • Robert KuhlingDirector
  • Bruce FeuchterExecutive Officer
  • Eric WichemsExecutive Officer, Director
  • Hugo HarrodDirector
  • Ittai HarelDirector
  • Rebecca ColbertExecutive Officer
Offering amount
$27.5M
Amount sold
$26.1M
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.8MraisedJun 2017 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ittai HarelDirector
  • Daniel PelakDirector
  • Michael BoggsDirector
  • Eric WichemsExecutive Officer, Director
  • John RyanDirector
  • Rebecca ColbertExecutive Officer
  • Bruce FeuchterExecutive Officer
Offering amount
$28.9M
Amount sold
$28.8M
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMay 2015 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John RyanDirector
  • Myles GreenbergDirector
  • Bruce FeuchterExecutive Officer
  • Eric WichemsExecutive Officer, Director
  • Daniel PelakDirector
  • Ittai HarelDirector
  • Rebecca ColbertExecutive Officer
Offering amount
$12M
Amount sold
$6M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Vertos Medical do?
Vertos Medical (part of Stryker's Interventional Spine business) develops minimally invasive interventional treatments for chronic pain and reduced mobility, including vertebral augmentation, bone tumor ablation, and basivertebral nerve ablation. Its products are aimed at physicians and clinicians treating patients with vertebral compression fractures, metastatic bone tumors, and related spinal conditions.
Who are Vertos Medical's investors?
Vertos Medical's investors include Norwest Venture Partners, MVM Life Science Partners, Pitango.
How much funding has Vertos Medical raised?
Vertos Medical has disclosed $122.2M raised across 5 of its 6 known rounds.
Where is Vertos Medical headquartered?
Vertos Medical is headquartered in Aliso Viejo, US.